Weight management to BMI 22-24

Suggested

2 studies · 1 recommendation

Last updated: February 14, 2026

Weight management to BMI 22-24 – Colorectal Cancer

Suggested2 studies

Maintaining a healthy BMI of 22-24 improves colorectal cancer survival outcomes

Two cohort studies totaling 1,192 colorectal cancer patients demonstrate that excess body weight significantly worsens prognosis. Among 1,011 stage III colon cancer patients, those who were overweight (BMI ≥25) and sedentary faced more than double the risk of disease recurrence or death (HR = 2.22; 95% CI, 1.29–3.81; P-trend = 0.0025). A separate retrospective cohort of 181 non-metastatic colorectal cancer surgery patients found that 75% were overweight or obese, and overweight status independently predicted poorer survival with a hazard ratio of 2.81 (P<0.05), even after adjusting for age, cancer stage, and physical capacity. Targeting a BMI of 22-24 through weight management—combining dietary modification with physical activity—may reduce recurrence risk and improve post-diagnosis survival.

Evidence

A retrospective cohort study of the influence of lifestyle factors on survival of patients undergoing surgery for colorectal cancer.

Authors: Anderson, Boyle, Campbell, Courneya, Courneya, Dignam, Haggar, Haydon, Holmes, Hubbard, Kuiper, Manceau, Martinez, Meyerhardt, Meyerhardt, Morrison, Oliphant, Shafique, Van Blarigan, Vartiainen, Vrieling, World Cancer Research Fund/American Institute for Cancer Research

Published: June 1, 2017

In a retrospective cohort of 181 non-metastatic colorectal cancer patients undergoing elective curative surgery in NHS Greater Glasgow & Clyde (2011-2012), 75% were overweight or obese at pre-operative assessment. BMI independently affected survival (P<0.05), with overweight patients showing a hazard ratio of 2.81 for poorer survival. Total follow-up was 480 person-years. BMI remained a significant independent prognostic factor after adjusting for age, histopathological stage, and physical capacity.

View Source →

Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)

Authors: Atienza, Daniel, Benson, Al, Fuchs, Michael A., Giovannucci, Edward, Hantel, Alexander, Kindler, Hedy, Mayer, Robert J., Messino, Michael, Meyerhardt, Jeffrey A., Mowat, Rex B., Niedzwiecki, Donna, Ogino, Shuji, Saltz, Leonard B., Sato, Kaori, Venook, Alan, Whittom, Renaud, Willett, Walter, Wu, Kana, Ye, Xing

Published: January 1, 2014

In a cohort study of 1,011 stage III colon cancer patients, the harmful association between sugar-sweetened beverage intake and cancer recurrence or mortality was most pronounced among patients who were both overweight (BMI ≥25 kg/m²) and less physically active. These patients consuming ≥2 servings of sugar-sweetened beverages daily experienced more than double the risk of disease recurrence or death (HR = 2.22; 95% CI, 1.29–3.81; P-trend = 0.0025). The study noted that obesity has been previously associated with increased risk of cancer recurrence in colon cancer patients.

View Source →